Oxpro Pharma Private Limited - Company Profile

It is a pharma private limited company based in Ranchi, Jharkhand, India, established in 2020.
2020 Ranchi, Jharkhand, India Active
Last Updated:
About Oxpro Pharma Private Limited

Oxpro Pharma Private Limited, a active private limited company, was established on 04 June 2020 in Ranchi, Jharkhand, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51909JH2020PTC014366. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

Employing 80 professional, Its leadership includes Sarita Kumari (Additional Director), Sanjay Kumar (Whole-Time Director), Saurabh Vidyarthi (Whole-Time Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Sanjay Kumar, F.N.-B2, 2Nd Floor, Wadhwani Tower, Karam Toli Chwok,, Ranchi, Jharkhand, 834008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909JH2020PTC014366

  • Registration Number

    014366

  • Incorporation Date

    04 June 2020

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Ranchi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 5 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 48.67%
  • Profit Growth **** 68.19%
  • Ebitda **** 72.17%
  • Net Worth 136.49%
  • Total Assets **** 70.91%
Company report

Oxpro Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Oxpro Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Oxpro Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sarita Kumari Additional Director 02 Dec 2021 Current
Sanjay Kumar Whole-Time Director 04 Jun 2020 Current
Saurabh Vidyarthi Whole-Time Director 04 Jun 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Oxpro Pharma.

Oxpro Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.67% increase. The company also saw a substantial improvement in profitability, with a 68.19% increase in profit. The company's net worth Soared by an impressive increase of 136.49%.

Oxpro Pharma revenue growth over time
Oxpro Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
48.67%
*******
*******
*******
*******
Revenue from Operations
*******
48.62%
*******
*******
*******
*******
Total Assets
*******
70.91%
*******
*******
*******
*******
Profit or Loss
*******
68.19%
*******
*******
*******
*******
Net Worth
*******
136.49%
*******
*******
*******
*******
EBITDA
*******
72.17%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Oxpro Pharma?

In 2021, Oxpro Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Oxpro Pharma?

Oxpro Pharma has a workforce of 80 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Oxpro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxpro Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Oxpro Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Oxpro Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Oxpro Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi. was documented.

  • Director Appointment

    The activity Sarita Kumari was appointed as a Additional Director was appointed as a Additional Director on 02 Dec 2021 & has been associated with this company since 4 years 3 months . was completed.

  • Director Appointment

    The activity Sanjay Kumar was appointed as a Whole-time director was appointed as a Whole-time director on 04 Jun 2020 & has been associated with this company since 5 years 9 months . was completed.

  • Director Appointment

    The activity Saurabh Vidyarthi was appointed as a Whole-time director was appointed as a Whole-time director on 04 Jun 2020 & has been associated with this company since 5 years 9 months . was completed.

  • Company Incorporation

    Oxpro Pharma Private Limited was registered on 04 Jun 2020 with Roc Ranchi & aged 5 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Oxpro Pharma Private Limited?

The CIN of Oxpro Pharma Private Limited is U51909JH2020PTC014366.

Where is Oxpro Pharma Private Limited headquartered?

Oxpro Pharma Private Limited is headquartered at C/O Sanjay Kumar, F.N.-B2, 2Nd Floor, Wadhwani Tower, Karam Toli Chwok,, Ranchi, Jharkhand, 834008.

When was Oxpro Pharma Private Limited incorporated?

Oxpro Pharma Private Limited was incorporated on 04 June 2020.

Who are the current directors of Oxpro Pharma Private Limited?

The current directors of Oxpro Pharma Private Limited are

What is the primary industry of Oxpro Pharma Private Limited?

The primary industry of Oxpro Pharma Private Limited is Manufacturing.

Is Oxpro Pharma Private Limited a listed company?

Oxpro Pharma Private Limited is unlisted.

What is the capital structure of Oxpro Pharma Private Limited?

The authorized capital of Oxpro Pharma Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available